Fiserv Valuation
Is FIV undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
1/6Valuation Score 1/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of FIV when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: FIV (CHF165.24) is trading below our estimate of fair value (CHF179.77)
Significantly Below Fair Value: FIV is trading below fair value, but not by a significant amount.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for FIV?
Other financial metrics that can be useful for relative valuation.
What is FIV's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$114.59b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 6.9x |
Enterprise Value/EBITDA | 15.9x |
PEG Ratio | 2x |
Price to Earnings Ratio vs Peers
How does FIV's PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 31.7x | ||
UBSG UBS Group | 44.2x | 31.5% | CHF 91.2b |
PGHN Partners Group Holding | 34.2x | 14.2% | CHF 32.8b |
PYPL PayPal Holdings | 18.5x | 5.7% | US$85.5b |
BAER Julius Bär Gruppe | 29.9x | 21.9% | CHF 11.2b |
FIV Fiserv | 37.3x | 18.7% | CHF 114.6b |
Price-To-Earnings vs Peers: FIV is expensive based on its Price-To-Earnings Ratio (37.3x) compared to the peer average (31.7x).
Price to Earnings Ratio vs Industry
How does FIV's PE Ratio compare vs other companies in the European Diversified Financial Industry?
Price-To-Earnings vs Industry: FIV is expensive based on its Price-To-Earnings Ratio (37.3x) compared to the European Diversified Financial industry average (11.6x).
Price to Earnings Ratio vs Fair Ratio
What is FIV's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 37.3x |
Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate FIV's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | CHF 165.24 | CHF 188.60 +14.1% | 9.1% | CHF 211.69 | CHF 138.81 | n/a | 33 |
Oct ’25 | CHF 149.99 | CHF 155.43 +3.6% | 6.3% | CHF 171.78 | CHF 131.16 | n/a | 33 |
Sep ’25 | CHF 143.81 | CHF 150.74 +4.8% | 7.9% | CHF 168.47 | CHF 109.51 | n/a | 33 |
Aug ’25 | n/a | CHF 157.24 0% | 7.7% | CHF 176.79 | CHF 114.91 | n/a | 32 |
Jul ’25 | n/a | CHF 154.38 0% | 7.6% | CHF 178.88 | CHF 116.27 | n/a | 34 |
Jun ’25 | n/a | CHF 157.11 0% | 8.5% | CHF 182.93 | CHF 118.91 | n/a | 33 |
May ’25 | n/a | CHF 154.89 0% | 8.5% | CHF 182.77 | CHF 118.80 | n/a | 34 |
Apr ’25 | CHF 139.65 | CHF 146.44 +4.9% | 8.1% | CHF 167.34 | CHF 117.59 | n/a | 34 |
Mar ’25 | n/a | CHF 140.00 0% | 7.7% | CHF 163.01 | CHF 114.55 | n/a | 34 |
Feb ’25 | n/a | CHF 131.25 0% | 9.2% | CHF 159.72 | CHF 111.11 | n/a | 34 |
Jan ’25 | n/a | CHF 124.71 0% | 10.5% | CHF 158.27 | CHF 102.66 | n/a | 32 |
Dec ’24 | n/a | CHF 124.81 0% | 8.3% | CHF 154.07 | CHF 105.65 | n/a | 31 |
Nov ’24 | n/a | CHF 127.51 0% | 8.9% | CHF 158.87 | CHF 108.94 | n/a | 32 |
Oct ’24 | n/a | CHF 127.24 0% | 8.4% | CHF 152.62 | CHF 99.65 | CHF 149.99 | 30 |
Sep ’24 | n/a | CHF 124.62 0% | 8.1% | CHF 149.23 | CHF 97.44 | CHF 143.81 | 31 |
Aug ’24 | CHF 108.56 | CHF 123.36 +13.6% | 8.5% | CHF 148.79 | CHF 97.15 | n/a | 32 |
Jul ’24 | n/a | CHF 120.48 0% | 7.6% | CHF 143.18 | CHF 99.33 | n/a | 32 |
Jun ’24 | n/a | CHF 118.70 0% | 8.3% | CHF 142.40 | CHF 97.90 | n/a | 31 |
May ’24 | n/a | CHF 118.82 0% | 8.0% | CHF 138.54 | CHF 98.32 | n/a | 31 |
Apr ’24 | n/a | CHF 116.35 0% | 9.7% | CHF 140.76 | CHF 91.40 | CHF 139.65 | 31 |
Mar ’24 | n/a | CHF 118.89 0% | 10.3% | CHF 144.14 | CHF 93.60 | n/a | 32 |
Feb ’24 | n/a | CHF 109.45 0% | 11.3% | CHF 140.02 | CHF 87.51 | n/a | 32 |
Jan ’24 | n/a | CHF 112.96 0% | 10.3% | CHF 142.31 | CHF 88.94 | n/a | 32 |
Dec ’23 | n/a | CHF 116.77 0% | 10.6% | CHF 146.72 | CHF 91.70 | n/a | 32 |
Nov ’23 | n/a | CHF 120.49 0% | 10.6% | CHF 151.31 | CHF 94.57 | n/a | 32 |
Oct ’23 | n/a | CHF 122.72 0% | 10.7% | CHF 149.98 | CHF 93.74 | n/a | 32 |
Analyst Forecast: Target price is less than 20% higher than the current share price.